Leadership Overview
Worldwide Clinical Trials has 7 executives leading key functions including strategy, finance, operations, medical affairs, human resources, and business unit management.
Driven by a commitment to advancing healthcare, Worldwide Clinical Trials delivers comprehensive clinical development services, focusing on critical therapeutic areas to accelerate the delivery of life-changing treatments to patients globally.
Driven by a commitment to advancing healthcare, Worldwide Clinical Trials delivers comprehensive clinical development services, focusing on critical therapeutic areas to accelerate the delivery of life-changing treatments to patients globally.
Leadership Roles at Worldwide Clinical Trials
Daniel Gizachew - Chief Executive Officer
Daniel Gizachew, the Chief Executive Officer at Worldwide Clinical Trials, directs the overarching strategy and operational execution for the global CRO. Gizachew guides the company's mission to provide top-performing preclinical and Phase I-IV clinical development services across the biotechnology and pharmaceutical sectors. This leadership role encompasses ensuring the seamless integration of bioanalytical sciences, early-phase research, late-phase studies, and post-approval services. Daniel Gizachew drives the company's expansion into major therapeutic areas, including Cardiovascular, Metabolic, Neuroscience, Oncology, and Rare Diseases, fostering an environment of innovation and client-centric solutions. The Chief Executive Officer's focus remains on enhancing the company's market position and delivering exceptional value to clients seeking to bring novel therapies to market.
Kevin Gordon - Interim Chief Financial Officer
Kevin Gordon, the Interim Chief Financial Officer at Worldwide Clinical Trials, oversees all financial operations and strategic fiscal planning for the organization. Gordon manages financial reporting, budgeting, forecasting, and capital allocation to support the company's growth objectives within the biotechnology and pharmaceutical industries. This critical role involves ensuring financial stability and optimizing resource deployment across preclinical and clinical development services. The Interim Chief Financial Officer works closely with other executive leaders to align financial strategies with the company's expansion into key therapeutic areas such as Cardiovascular, Metabolic, Neuroscience, Oncology, and Rare Diseases. Kevin Gordon's leadership ensures robust financial governance and supports the company's commitment to delivering high-quality clinical trial management.
Keya Watkins - President, Oncology
Keya Watkins, the President, Oncology at Worldwide Clinical Trials, spearheads the strategic direction and operational execution for all oncology-related clinical development services. Watkins drives the company's focus on advancing treatments for various cancer types, leveraging deep expertise in preclinical research and Phase I-IV clinical trials. This leadership role involves managing dedicated teams and resources to support clients in the biotechnology and pharmaceutical industries targeting oncology indications. Keya Watkins ensures that oncology studies adhere to the highest scientific and regulatory standards, contributing significantly to the company's specialized therapeutic area capabilities. The President, Oncology's leadership is instrumental in accelerating the development of novel cancer therapies and expanding the company's impact in this critical field.
Alessandra Vignola - President, Cardiovascular & Metabolic Business Unit
Alessandra Vignola, the President, Cardiovascular & Metabolic Business Unit at Worldwide Clinical Trials, directs the strategic growth and operational success of the company's cardiovascular and metabolic clinical development services. Vignola leads initiatives focused on advancing treatments for heart disease, diabetes, and related metabolic disorders, overseeing preclinical and Phase I-IV clinical trials. This executive position ensures that clients in the biotechnology and pharmaceutical sectors receive specialized support tailored to these complex therapeutic areas. Alessandra Vignola fosters collaboration among scientific, clinical, and operational teams to deliver high-quality, efficient trial management. The President, Cardiovascular & Metabolic Business Unit's expertise is crucial for accelerating the delivery of innovative therapies to patients worldwide.
Lisa Skorets - Chief Of Staff, GCD
Lisa Skorets, the Chief Of Staff, GCD at Worldwide Clinical Trials, provides strategic support and operational oversight to the Global Clinical Development (GCD) function. Skorets facilitates cross-departmental collaboration, ensuring alignment between preclinical, Phase I-IV clinical development services, and post-approval research. This role is pivotal in streamlining operations and enhancing the efficiency of clinical trial execution across major therapeutic areas like Cardiovascular, Metabolic, Neuroscience, Oncology, and Rare Diseases. Lisa Skorets drives initiatives that support the company's mission to accelerate the delivery of innovative treatments. The Chief Of Staff, GCD ensures that global clinical development strategies are effectively implemented, contributing directly to the company's reputation for top-performing services.
Juergen Frisch - Chief Medical Officer
Juergen Frisch, the Chief Medical Officer at Worldwide Clinical Trials, directs the medical strategy and clinical research oversight for the organization. Frisch leads the scientific direction for preclinical and Phase I-IV clinical development services, ensuring the highest standards of medical integrity and patient safety. This executive role involves guiding the company's expertise in major therapeutic areas, including Cardiovascular, Metabolic, Neuroscience, Oncology, and Rare Diseases. Juergen Frisch collaborates with clients to design and execute complex clinical trials, leveraging deep medical knowledge to achieve study objectives. The Chief Medical Officer's contributions are essential to Worldwide Clinical Trials' ability to provide comprehensive, high-quality clinical development solutions to the biotechnology and pharmaceutical industries.
Joy Clark - Chief People Officer
Joy Clark, the Chief People Officer at Worldwide Clinical Trials, leads all human resources functions and talent management strategies. Clark is responsible for cultivating a high-performance culture that supports the company's mission to deliver exceptional preclinical and clinical development services. This executive position involves overseeing talent acquisition, employee development, compensation, benefits, and fostering an inclusive work environment across global operations. Joy Clark plays a key role in ensuring that Worldwide Clinical Trials attracts and retains top talent necessary for success in the competitive biotechnology and pharmaceutical sectors. The Chief People Officer's focus on people empowers the organization to effectively manage clinical trials in critical areas such as Cardiovascular, Metabolic, Neuroscience, Oncology, and Rare Diseases.
Explore Leadership Teams in Business Services
Pacific Northwest National Laboratory is one of the United States Department of Energy national laboratories, managed by the Department of Energy's Office of Science. The main campus of the laboratory is in Richland, Washington.
Company Leadership DK
CN
Mercedes-Benz Research & Development India (MBRDI), headquartered in Karnataka, India and founded in 1996, is a research and development center for Daimler.
Company Leadership
DV
HP
The National Laboratory of the Rockies, located in Golden, Colorado, is a national laboratory of the United States Department of Energy specializing in energy systems research and development. Formerly known as the National Renewable Energy Laboratory until December 2025, NLR serves as the primary federal laboratory for advancing energy technologies across the entire energy spectrum, from generation to distribution to end use. The laboratory conducts multidisciplinary research in renewable energy, energy efficiency, energy systems integration, sustainable transportation, bioenergy, photovoltaics, wind energy, hydrogen and fuel cells, energy storage, and advanced materials science. NLR operates state-of-the-art research facilities including the Energy Systems Integration Facility, Solar Energy Research Facility, and maintains high-performance computing capabilities. The laboratory partners with industry, government agencies, academia, and other national laboratories to bridge foundational research with practical applications. NLR develops data sets, analytical tools, and models for energy technology analysis while working to lower energy costs, drive economic growth, strengthen national security, and ensure abundant energy for the nation. The laboratory maintains campuses in Golden and Arvada, Colorado, as well as Fairbanks, Alaska, and is operated under contract for the Department of Energy's Office of Critical Minerals and Energy Innovation by the Alliance for Sustainable Energy.
Company Leadership SH
GH
MH
Founded in 1982, DEKA researches, develops, designs, and manufactures advanced technologies, such as water filtration systems, robotic prostheses, medical treatment solutions, power converters, and more. Their headquarters is located in Manchester, New Hampshire.
Company Leadership VD
DT
CC
IS
Frequently Asked Questions Regarding Worldwide Clinical Trials Top Executives and Leadership Team
